Producer
Chr. Hansen Holding
Founded 1874 as a butter culture supplier; now global biotech leader in dairy, food, and animal health. Market-leading supplier of mesophilic lactic acid bacteria cultures for cultured butter worldwide.
1
Inputs supplied
1
Goods downstream
2
Facilities
0
Stories
What they make
1 input Chr. Hansen Holding supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up
Goods downstream
Essential goods that depend on something Chr. Hansen Holding makes — pick one to see the full supply chain.
Where they make it
2 facilities
Chr. Hansen Hørsholm R&D & Production Campus →
DKHørsholm · culture production and R&D
Founding site (1874) and global headquarters; primary production and R&D for dairy starter cultures, freeze-dried bacterial concentrates, and bacteriophage resistance programs.
Chr. Hansen Milwaukee Production Facility →
USMilwaukee, Wisconsin · fermentation
North American production hub for Chr. Hansen dairy cultures; freeze-drying and packaging of mesophilic and thermophilic starter cultures for US and Latin American markets.
What else they do
Business segments
The company's full revenue map — where this supply-chain role fits within their broader business.
Dairy and Food Cultures
50%Health and Nutrition (Probiotics)
25%Natural Colors
15%Enzymes and Fermentation Media
10%
Intelligence
What's known
Sourced claims about this company's role in supply chains — chokepoints, concentration, incidents, dual-use connections.
Did you know2023
Chr. Hansen is publicly known as a dairy culture company, but their BB-12 probiotic strain (Bifidobacterium animalis subsp. lactis BB-12) is simultaneously the most documented probiotic strain in clinical research AND an ingredient in dozens of consumer probiotic supplement brands (Culturelle, etc.) AND an additive in premium infant formulas AND the same organism grown for veterinary probiotic applications. The exact same bacterial strain is simultaneously classified as: a food ingredient (in yogurt), a dietary supplement (in probiotic capsules), an infant formula ingredient (functional for immune and gut health), and an animal health product (for poultry gut microbiome). The regulatory and product category boundaries between food, supplement, pharmaceutical, and veterinary markets are crossed by one bacterial strain from one Danish company. When FDA regulatory policy on probiotic health claims changes, or when antibiotic resistance research links probiotic strains to resistance gene transfer, the same policy decision affects Chr. Hansen's dairy, supplement, infant formula, and veterinary markets simultaneously.
Chr. Hansen Holding ↗Chokepoint2023
Chr. Hansen has supplied dairy starter cultures continuously since 1874 and is estimated to hold ~40% of the global mesophilic starter culture market. Its Hørsholm, Denmark campus is the single largest concentration of starter culture R&D and production in the world. A bacteriophage contamination event at Hørsholm — the primary risk vector, as phages can sweep through a production facility within hours — would remove the ability to supply ~40% of global butter and cheese producers simultaneously.
MarketsandMarkets ↗Origin
Chr. Hansen was founded in 1874 specifically as a butter culture supplier before evolving into a global biotech company — meaning the lactic acid bacteria strains that define the flavor of premium European butter today trace back to cultures developed over 150 years ago by a Danish pharmacist named Christian D.A. Hansen.
Dairy Connection ↗